1. Home
  2. ALAR vs GNTA Comparison

ALAR vs GNTA Comparison

Compare ALAR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$7.84

Market Cap

57.1M

Sector

Technology

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.44

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
GNTA
Founded
2013
2014
Country
Israel
Italy
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
34.0M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ALAR
GNTA
Price
$7.84
$1.44
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$27.00
N/A
AVG Volume (30 Days)
82.2K
92.8K
Earning Date
11-26-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$36,305,000.00
N/A
Revenue This Year
$31.17
N/A
Revenue Next Year
$30.14
N/A
P/E Ratio
$47.33
N/A
Revenue Growth
15.03
N/A
52 Week Low
$5.45
$1.28
52 Week High
$18.00
$10.00

Technical Indicators

Market Signals
Indicator
ALAR
GNTA
Relative Strength Index (RSI) 31.52 36.07
Support Level $7.46 $1.28
Resistance Level $7.93 $1.68
Average True Range (ATR) 0.35 0.17
MACD 0.23 0.02
Stochastic Oscillator 59.09 27.42

Price Performance

Historical Comparison
ALAR
GNTA

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: